COVID-19 Early Treatment Options - where are they?
Micky Turner made this Official Information request to Pharmaceutical Management Agency
The request was successful.
From: Micky Turner
Dear Pharmaceutical Management Agency,
Can you please advise if you have organized the supply of and are offering people with Covid-19 any of the following:
Fluvoxamine 89%
Budesonide 81%
Vitamin D 81%
Vitamin A 79%
Quercetin 79%
Melatonin 78%
Zinc 74%
Povidone-Iodine 71%
Sotrovimab 67%
Ivermectin 67%
Vitamin C 43%
Aspirin 21%
I have included their early treatment efficacy % beside each one. This information can be found at c19early.com
These vitamins and OTC meds should by now be being handed out to everyone with Covid 19 and their close contacts:
Vitamin D 81%
Vitamin A 79%
Quercetin 79%
Melatonin 78%
Zinc 74%
Povidone-Iodine 71%
Vitamin C 43%
Aspirin 21%
Ivermectin should also be given to people who wish to take it, so long as they have been shown the various study data and give informed consent. At worst they may get diarrhea - at best - it may save their life.
The Ministry of Health should also have enough Budesonide and inhalers for 100,000 people.
You have had 20 months to prepare for this. People are now dying. We no longer have time to play politics or who has the biggest medical degree. We need to take notice of the data and respond rapidly.
- Micky Turner
From: Web Enquiry
Pharmaceutical Management Agency
Kia ora Micky
Thank you for your email.
Your request has been received and logged. Our reference number for your request is 2021-22-061.
As required under the Official Information Act 1982, we will respond to your request within 20 working days. You should receive a response on or before 10 December 2021.
If a large amount of information has been requested, we may need to extend this date (this is provided for in section 15A of the Act). We will advise you if such an extension is necessary.
Ngā mihi
Melody Willis (she/her) | Government Services Advisor
___________________________________________________________________
Te Pātaka Whaioranga | Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
P: +64 4 460 4990 |www.pharmac.govt.nz
-----Original Message-----
From: Micky Turner <[FOI #17559 email]>
Sent: Saturday, 13 November 2021 7:09 pm
To: Web Enquiry <[email address]>
Subject: Official Information request - COVID-19 Early Treatment Options - where are they?
[You don't often get email from [FOI #17559 email]. Learn why this is important at http://aka.ms/LearnAboutSenderIdentifica...
Dear Pharmaceutical Management Agency,
Can you please advise if you have organized the supply of and are offering people with Covid-19 any of the following:
Fluvoxamine 89%
Budesonide 81%
Vitamin D 81%
Vitamin A 79%
Quercetin 79%
Melatonin 78%
Zinc 74%
Povidone-Iodine 71%
Sotrovimab 67%
Ivermectin 67%
Vitamin C 43%
Aspirin 21%
I have included their early treatment efficacy % beside each one. This information can be found at c19early.com
These vitamins and OTC meds should by now be being handed out to everyone with Covid 19 and their close contacts:
Vitamin D 81%
Vitamin A 79%
Quercetin 79%
Melatonin 78%
Zinc 74%
Povidone-Iodine 71%
Vitamin C 43%
Aspirin 21%
Ivermectin should also be given to people who wish to take it, so long as they have been shown the various study data and give informed consent. At worst they may get diarrhea - at best - it may save their life.
The Ministry of Health should also have enough Budesonide and inhalers for 100,000 people.
You have had 20 months to prepare for this. People are now dying. We no longer have time to play politics or who has the biggest medical degree. We need to take notice of the data and respond rapidly.
- Micky Turner
-------------------------------------------------------------------
This is an Official Information request made via the FYI website.
Please use this email address for all replies to this request:
[FOI #17559 email]
Is [PHARMAC request email] the wrong address for Official Information requests to Pharmaceutical Management Agency? If so, please contact us using this form:
https://fyi.org.nz/change_request/new?bo...
Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers
If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.
-------------------------------------------------------------------
This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.
hide quoted sections
From: Micky Turner
Dear Web Enquiry,
Pharmac's response to this has been sent to another OIA.
Just while we are waiting for the response to be transferred to here - can you please let me know the following:
Can Pharmac purchase dietary supplements if there is supporting evidence those supplements likely reduce hospitalization and mortality?
Zinc + ionophore (Quercetin or Hinokitiol)
Vitamin D
Vitamin K
Cheers - Micky
From: Web Enquiry
Pharmaceutical Management Agency
Kia ora Micky
Can I please confirm your below question still relates specifically to people with COVID-19?
Ngā mihi
Melody Willis (she/her) | Government Services Advisor
___________________________________________________________________
Te Pātaka Whaioranga | Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
P: +64 4 460 4990 |www.pharmac.govt.nz
Te Pātaka Whaioranga, Pharmac, will be closed from 25 December 2021 to 4 January 2022 inclusive.
Click here to read more about our summer holiday hours on our website.
-----Original Message-----
From: Micky Turner <[FOI #17559 email]>
Sent: Sunday, 12 December 2021 9:54 am
To: Web Enquiry <[email address]>
Subject: RE: Official Information request - COVID-19 Early Treatment Options - where are they?
[You don't often get email from [FOI #17559 email]. Learn why this is important at http://aka.ms/LearnAboutSenderIdentifica...
Dear Web Enquiry,
Pharmac's response to this has been sent to another OIA.
Just while we are waiting for the response to be transferred to here - can you please let me know the following:
Can Pharmac purchase dietary supplements if there is supporting evidence those supplements likely reduce hospitalization and mortality?
Zinc + ionophore (Quercetin or Hinokitiol) Vitamin D Vitamin K
Cheers - Micky
-----Original Message-----
Kia ora Micky
Thank you for your email.
Your request has been received and logged. Our reference number for your request is 2021-22-061.
As required under the Official Information Act 1982, we will respond to your request within 20 working days. You should receive a response on or before 10 December 2021.
If a large amount of information has been requested, we may need to extend this date (this is provided for in section 15A of the Act). We will advise you if such an extension is necessary.
Ngā mihi
Melody Willis (she/her) | Government Services Advisor ___________________________________________________________________
Te Pātaka Whaioranga | Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
P: +64 4 460 4990 |www.pharmac.govt.nz
-------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #17559 email]
Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers
If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.
-------------------------------------------------------------------
This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.
hide quoted sections
From: Web Enquiry
Pharmaceutical Management Agency
Tēnā koe Micky
Pharmac is continuing to evaluate potential treatments for COVID-19 as
evidence emerges.
We are happy to consider funding applications for COVID-19 treatments that
have not yet been considered by Pharmac.
[1]Records of the most recent treatments that have been considered for
funding by Pharmac have been published on our website:
[2]www.pharmac.govt.nz/about/expert-advice/advisory-groups/
Ngā mihi
Melody Willis ([3]she/her) | Government Services Advisor
___________________________________________________________________
Te Pātaka Whaioranga | Pharmac | PO Box 10 254 | Level 9, 40 Mercer
Street, Wellington
P: +64 4 460 4990 |[4]www.pharmac.govt.nz
-----Original Message-----
From: Micky Turner <[FOI #17559 email]>
Sent: Sunday, 12 December 2021 9:54 am
To: Web Enquiry <[email address]>
Subject: RE: Official Information request - COVID-19 Early Treatment
Options - where are they?
[You don't often get email from
[5][FOI #17559 email]. Learn why this is
important at [6]http://aka.ms/LearnAboutSenderIdentifica...
Dear Web Enquiry,
Pharmac's response to this has been sent to another OIA.
Just while we are waiting for the response to be transferred to here - can
you please let me know the following:
Can Pharmac purchase dietary supplements if there is supporting evidence
those supplements likely reduce hospitalization and mortality?
Zinc + ionophore (Quercetin or Hinokitiol) Vitamin D Vitamin K
Cheers - Micky
This e-mail message and any accompanying attachments may contain
confidential information. If you are not the intended recipient, please do
not read, use, disseminate, distribute or copy this message or
attachments. If you have received this message in error, please notify the
sender immediately and delete this message.
References
Visible links
1. https://pharmac.govt.nz/about/expert-adv...
2. https://pharmac.govt.nz/about/expert-adv...
3. https://www.publicservice.govt.nz/our-wo...
4. file:///tmp/www.pharmac.govt.nz
5. mailto:[FOI #17559 email]
6. http://aka.ms/LearnAboutSenderIdentifica...
hide quoted sections
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Offensive? Unsuitable?
Requests for personal information and vexatious requests are not considered valid requests for Official Information (read more).
If you believe this request is not suitable, you can report it for attention by the site administrators
Report this requestAct on what you've learnt
Similar requests
Decision not to provide information to Today FM or Mediaworks
To Pharmaceutical Management Agency by New Zealand Council for Civil Liberties
